Five Prime Therapeutics, Inc.
Filing:
10-K
Filed On:
02/27/20  4:33 PM  EST
Share Print
PDF PDF of All Exhibits Download All Tables Compare
Exhibits
10-K
from 10-K 126 pages 10-K
02/27/20
EX-4.2
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
02/27/20
EX-10.17
from 10-K 1 page December 20, 2019 Mr. William R. Ringo via Electronic Mail Five Prime Therapeutics, Inc. /S/ Peder Jensen Peder Jensen Chairman of the Compensation and Management Development Committee of the Board of Directors Accepted: /S/ William R. Ringo William R. Ringo
02/27/20
EX-10.21
from 10-K 1 page December 12, 2019 Five Prime Therapeutics, Inc. /S/ William R. Ringo William R. Ringo Chief Executive Officer Understood, Accepted and Agreed: /S/ Francis Sarena December 12, 2019 Francis Sarena Date
02/27/20
EX-10.23
from 10-K 1 page December 12, 2019 Five Prime Therapeutics, Inc. /S/ William R. Ringo William R. Ringo Chief Executive Officer Understood, Accepted and Agreed: /S/ David Smith December 12, 2019 David Smith Date
02/27/20
EX-10.24
from 10-K 2 pages January 15, 2020 David Smith via Hand Delivery Re: Retention Bonus
02/27/20
EX-10.25
from 10-K 2 pages January 15, 2020 Helen Collins, M.D. via Hand Delivery Re: Retention Bonus
02/27/20
EX-10.26
from 10-K 2 pages January 15, 2020 Francis Sarena via Hand Delivery Re: Retention Bonus
02/27/20
EX-10.28
from 10-K 1 page December 12, 2019 Five Prime Therapeutics, Inc. /S/ William R. Ringo William R. Ringo Chief Executive Officer Understood, Accepted and Agreed: /S/ Helen Collins, M.D. December 12, 2019 Helen Collins, M.D. Date
02/27/20
EX-10.33
from 10-K 11 pages Five Prime Therapeutics, Inc. Executive Severance Benefit Plan and Summary Plan Description
02/27/20
EX-10.34
from 10-K ~1 page Non-Employee Director Compensation Policy
02/27/20
EX-23.1
from 10-K 1 page Consent of expert or counsel
02/27/20
EX-31.1
from 10-K 1 page Management certification of annual or quarterly disclosure
02/27/20
EX-31.2
from 10-K 1 page Management certification of annual or quarterly disclosure
02/27/20
EX-32.1
from 10-K 1 page Management certification of financial report
02/27/20
EX-32.2
from 10-K 1 page Management certification of financial report
02/27/20
Graphics & Data Files
GRAPHIC
from 10-K gpktmgmbdvdk000001.jpg
02/27/20
GRAPHIC
from 10-K ghf0ywk0oqdb000001.jpg
02/27/20
GRAPHIC
from 10-K gauok3pedeyx000001.jpg
02/27/20
GRAPHIC
from 10-K gegyn1zebmeo000001.jpg
02/27/20
GRAPHIC
from 10-K g1e1m4n0ttpy000001.jpg
02/27/20
GRAPHIC
from 10-K guakm44ii2gy000001.jpg
02/27/20
GRAPHIC
from 10-K gztszko44w5y000001.jpg
02/27/20
GRAPHIC
from 10-K gauok3pedeyx000002.jpg
02/27/20
GRAPHIC
from 10-K gcp4mpt1aaph000001.jpg
02/27/20
External Links